Lu M.-C.Lai N.-S.KO-JEN LISONG-CHOU HSIEHCHENG-HAN WUCHIA-LI YU2021-01-272021-01-2720080392-856Xhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-52749086076&partnerID=40&md5=70c994db69f6f83cc88fdd26e37c6b55https://scholars.lib.ntu.edu.tw/handle/123456789/542203[SDGs]SDG3azathioprine; breast cancer resistance protein; corticosteroid; cyclophosphamide; dichlorodihydrofluorescein diacetate; glycoprotein P; hydroxychloroquine; mitoxantrone; multidrug resistance protein; multidrug resistance protein 1; multidrug resistance protein 2; multidrug resistance protein 3; prednisolone; rhodamine 123; adult; article; cell isolation; cell transport; clinical article; controlled study; correlation function; drug response; female; flow cytometry; human; human cell; long term care; male; mononuclear cell; multidrug resistance; neutrophil; priority journal; protein expression; protein function; systemic lupus erythematosus; therapy resistance; treatment duration; volunteer; Adrenal Cortex Hormones; Adult; Case-Control Studies; Female; Humans; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Male; Middle Aged; Mitoxantrone; Multidrug Resistance-Associated Proteins; Neutrophils; Rhodamines; Young AdultIncreased multidrug resistance-associated protein activity in mononuclear cells of patients with systemic lupus erythematosusjournal article187990962-s2.0-52749086076